Otorhinolaryngology Unit, Humanitas Clinical and Research Center IRCCS, Rozzano (MI), Italy.
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy.
Head Neck. 2021 Mar;43(3):987-996. doi: 10.1002/hed.26536. Epub 2020 Nov 9.
To define the accuracy of fine-needle aspiration cytology (FNAC) in diagnosing persistent or recurrent neck metastases in previously irradiated patients.
The study was performed according to the PRISMA-DTA guidelines.
A total of 382 FNACs were used for calculation of diagnostic accuracy parameters. The overall pooled sensitivity and specificity in detecting malignant nodes were 69.1% (95% CI: 56.3%-80.7%; I = 79.5%) and 84.2% (95% CI: 71.8%-93.5%; I = 87.0%), respectively. Cumulative diagnostic odds ratio (DOR) was 16.54 (95% CI: 4.89-38.99; I = 65.8%), while cumulative positive and negative likelihood ratio (PLR and NLR) were 5.4 (95% CI: 2.3-11.2) and 0.37 (95% CI: 0.22-0.54), respectively.
FNAC alone could not guide the decision to perform a salvage neck dissection in previously irradiated patients, but its results should be assessed in relation to the specific clinical context.
定义细针穿刺细胞学(FNAC)在诊断既往放疗后患者持续性或复发性颈部转移中的准确性。
本研究根据 PRISMA-DTA 指南进行。
共使用 382 例 FNAC 来计算诊断准确性参数。检测恶性淋巴结的总体汇总敏感性和特异性分别为 69.1%(95%CI:56.3%-80.7%;I = 79.5%)和 84.2%(95%CI:71.8%-93.5%;I = 87.0%)。累积诊断优势比(DOR)为 16.54(95%CI:4.89-38.99;I = 65.8%),而累积阳性和阴性似然比(PLR 和 NLR)分别为 5.4(95%CI:2.3-11.2)和 0.37(95%CI:0.22-0.54)。
FNAC 本身不能指导对既往放疗后患者进行挽救性颈部清扫的决策,但应根据具体的临床情况评估其结果。